안과 기기 시장 규모, 점유율과 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문 예측(2026-2033년)

Ophthalmic Devices Market Summary

The global ophthalmic devices market size was valued at USD 20.5 billion in 2025 and is projected to reach USD 39.1 billion by 2033, growing at a CAGR of 8.6% from 2026 to 2033. The growth of the market can be attributed to the rising prevalence of optical disorders, such as glaucoma, cataracts, diabetic retinopathy, and vitreoretinal disorders, coupled with technological advancements in ophthalmic surgical as well as diagnostic instruments required for these target applications.

Improved government initiatives to increase market base for visual impairment, thereby expanding the market for growth. For instance, in May 2024, the World Health Organization (WHO) initiated the SPECS 2030 program to assist countries in meeting the global eye care goal of a 40% increase in access to appropriate spectacles for people.

The growing geriatric population is increasing the demand for ophthalmic devices as they are more susceptible to age-related ophthalmic disorders. According to the National Institute of Aging (NIA), the geriatric population is expected to reach around 72 million by 2030. The increasing prevalence of diabetes and the incidence of diabetes-related blindness are predicted to fuel market growth. According to the World Health Organization (WHO), nearly 422 million people worldwide have diabetes, and the majority live in low and middle-income countries.

Increased screen time, has been associated with the onset and progression of various eye diseases, thus increasing the demand for eye examinations. For instance, in May 2024, Prevent Blindness, a non-profit volunteering organization focused on preventing blindness and preserving sight through public and professional education, community, and patient service programs, launched the "It Started with an Eye Exam" campaign to encourage consumers to provide their stories about how eye care positively impacts their health. This campaign was funded by Vitaris, Inc., a healthcare company that holistically bridges the gap between generic and branded medications to address global healthcare needs.

Technological advancements have enabled accurate diagnosis and improved treatment of ophthalmic disorders. Advancements in medications, diagnostic devices, laser technology, and surgical techniques have improved the handling of cataracts and macular degeneration, glaucoma, and dry eye disease.

Market players are also developing advanced products to meet the demand for these products. For instance, in April 2023, Bausch & Lomb announced the launch of ophthalmic viscosurgical devices in the United States. In March 2023, WaveFront Dynamics Inc. announced the commercial launch of its WaveDyn vision Analyzer. Such initiatives help increase awareness about eye diseases and the availability of diagnostic equipment.

Global Ophthalmic Devices Market Report Segmentation

This report forecasts country-level revenue growth and analyzes the latest industry trends and opportunities in each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the global ophthalmic devices market report based on product, application, end-use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Optical Coherence Tomography Scanners
• Fundus Camera
• Perimeters/Visual Field Analyzers
• Autorefractors and Keratometers
• Ophthalmic Ultrasound Imaging Systems
  • Ophthalmic A-Scan Ultrasound
  • Ophthalmic B-Scan Ultrasound
  • Ophthalmic Ultrasound Biomicroscopes
  • Ophthalmic Pachymeters
• Tonometers
• Slit Lamps
• Phoropters
• Wavefront Aberrometers
• Optical Biometry Systems
• Ophthalmoscopes
• Lensmeters
• Corneal Topography Systems
• Specular Microscopes
• Retinoscopes
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Cataract
• Vitreo Retinal Disorders
• Glaucoma
• Refractor Disorders
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals and Eye Clinics
• Academic and Research Laboratories
• Others
• Region Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Ophthalmic Devices Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Pricing Analysis
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
    • 3.3.1.1. Rising prevalence of eye disease
    • 3.3.1.2. Technological advancements in ophthalmic surgical and diagnostic instruments
    • 3.3.1.3. Government initiatives for increasing awareness related to visual impairment
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. Lack of trained ophthalmologists in developing nations
    • 3.3.2.2. High cost of devices in developing economies
  • 3.3.3. Market Challenge Analysis
• 3.4. Ophthalmic Devices Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Bargaining power of suppliers
    • 3.4.1.2. Bargaining power of buyers
    • 3.4.1.3. Threat of substitutes
    • 3.4.1.4. Threat of new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political & Legal Landscape
    • 3.4.2.2. Economic and Social Landscape
    • 3.4.2.3. Technological landscape

Chapter 4. Ophthalmic Devices Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Ophthalmic Devices Market: Product Movement Analysis
• 4.3. Ophthalmic Devices Market by Product Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 4.5. Optical Coherence Tomography (OCT)
  • 4.5.1. Optical Coherence Tomography (OCT) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Fundus Camera
  • 4.6.1. Fundus Camera Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Perimeters/Visual Field Analyzers
  • 4.7.1. Perimeters/Visual Field Analyzers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Autorefractors and Keratometers
  • 4.8.1. Autorefractors and Keratometers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.9. Ophthalmic Ultrasound Imaging Systems
  • 4.9.1. Ophthalmic Ultrasound Imaging Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9.2. Ophthalmic A-Scan Ultrasound
    • 4.9.2.1. Ophthalmic A-Scan Ultrasound Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9.3. Ophthalmic B-Scan Ultrasound
    • 4.9.3.1. Ophthalmic B-Scan Ultrasound Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9.4. Ophthalmic Ultrasound Biomicroscopes
    • 4.9.4.1. Ophthalmic Ultrasound Biomicroscopes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.10. Ophthalmic Pachymeters
  • 4.10.1. Ophthalmic Pachymeters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.11. Tonometers
  • 4.11.1. Tonometers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.12. Slit Lamps
  • 4.12.1. Slit Lamps Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.13. Phoropters
  • 4.13.1. Phoropters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.14. Wavefront Aberrometers
  • 4.14.1. Wavefront Aberrometers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.15. Optical Biometry Systems
  • 4.15.1. Optical Biometry Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.16. Ophthalmoscopes
  • 4.16.1. Ophthalmoscopes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.17. Lensometers
  • 4.17.1. Lensometers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.18. Corneal Topography Systems
  • 4.18.1. Corneal Topography Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.19. Specular Microscopes
  • 4.19.1. Specular Microscopes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.20. Retinoscopes
  • 4.20.1. Retinoscopes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Ophthalmic Devices Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Ophthalmic Devices Market: Application Movement Analysis
• 5.3. Ophthalmic Devices Market by Application Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 5.5. Cataract
  • 5.5.1. Cataract Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.2. Vitreo Retinal Disorders
    • 5.5.2.1. Vitreo Retinal Disorders Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.3. Glaucoma
    • 5.5.3.1. Glaucoma Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5.4. Refractive Disorders
    • 5.5.4.1. Refractive Disorders Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Ophthalmic Devices Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Ophthalmic Devices Market: End Use Movement Analysis
• 6.3. Ophthalmic Devices Market by End Use Outlook (Revenue, USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 6.5. Hospitals and Eye Clinics
  • 6.5.1. Hospitals and Eye Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Academic and Research Laboratory
  • 6.6.1. Academic and Research Laboratory Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Ophthalmic Devices Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Ophthalmic Devices Market: Regional Movement Analysis
• 7.3. Ophthalmic Devices Market: Regional Estimates & Trend Analysis by Product & End Use
• 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 7.5. North America
  • 7.5.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement Scenario
    • 7.5.2.5. U.S. market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement Scenario
    • 7.5.3.5. Canada market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Reimbursement Scenario
    • 7.5.4.5. Mexico market estimates and forecast, 2021 - 2033 (USD Million)
• 7.6. Europe
  • 7.6.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. UK
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement Scenario
    • 7.6.2.5. UK market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement Scenario
    • 7.6.3.5. Germany market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement Scenario
    • 7.6.4.5. France market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement Scenario
    • 7.6.5.5. Italy market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Reimbursement Scenario
    • 7.6.6.5. Spain market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.6.7. Denmark
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Reimbursement Scenario
    • 7.6.7.5. Denmark market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Key Country Dynamics
    • 7.6.8.2. Competitive Scenario
    • 7.6.8.3. Regulatory Framework
    • 7.6.8.4. Reimbursement Scenario
    • 7.6.8.5. Sweden market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.6.9. Norway
    • 7.6.9.1. Key Country Dynamics
    • 7.6.9.2. Competitive Scenario
    • 7.6.9.3. Regulatory Framework
    • 7.6.9.4. Reimbursement Scenario
    • 7.6.9.5. Norway market estimates and forecast, 2021 - 2033 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. Japan
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Reimbursement Scenario
    • 7.7.2.5. Japan market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.7.3. China
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Reimbursement Scenario
    • 7.7.3.5. China market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.7.4. India
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Framework
    • 7.7.4.4. Reimbursement Scenario
    • 7.7.4.5. India market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Framework
    • 7.7.5.4. Reimbursement Scenario
    • 7.7.5.5. South Korean market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.7.6. Australia
    • 7.7.6.1. Key Country Dynamics
    • 7.7.6.2. Competitive Scenario
    • 7.7.6.3. Regulatory Framework
    • 7.7.6.4. Reimbursement Scenario
    • 7.7.6.5. Australia market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.7.7. Thailand
    • 7.7.7.1. Key Country Dynamics
    • 7.7.7.2. Competitive Scenario
    • 7.7.7.3. Regulatory Framework
    • 7.7.7.4. Reimbursement Scenario
    • 7.7.7.5. Thailand market estimates and forecast, 2021 - 2033 (USD Million)
• 7.8. Latin America
  • 7.8.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.2. Brazil
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Reimbursement Scenario
    • 7.8.2.5. Brazil market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.8.3. Argentina
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Reimbursement Scenario
    • 7.8.3.5. Argentina market estimates and forecast, 2021 - 2033 (USD Million)
• 7.9. Middle East & Africa
  • 7.9.1. Middle East & Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.9.2. South Africa
    • 7.9.2.1. Key Country Dynamics
    • 7.9.2.2. Competitive Scenario
    • 7.9.2.3. Regulatory Framework
    • 7.9.2.4. Reimbursement Scenario
    • 7.9.2.5. South Africa market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.9.3. Saudi Arabia
    • 7.9.3.1. Key Country Dynamics
    • 7.9.3.2. Competitive Scenario
    • 7.9.3.3. Regulatory Framework
    • 7.9.3.4. Reimbursement Scenario
    • 7.9.3.5. Saudi Arabia market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.9.4. UAE
    • 7.9.4.1. Key Country Dynamics
    • 7.9.4.2. Competitive Scenario
    • 7.9.4.3. Regulatory Framework
    • 7.9.4.4. Reimbursement Scenario
    • 7.9.4.5. UAE market estimates and forecast, 2021 - 2033 (USD Million)
  • 7.9.5. Kuwait
    • 7.9.5.1. Key Country Dynamics
    • 7.9.5.2. Competitive Scenario
    • 7.9.5.3. Regulatory Framework
    • 7.9.5.4. Reimbursement Scenario
    • 7.9.5.5. Kuwait market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
• 8.3. Market Share & Position Analysis, 2025
  • 8.3.1. Johnson & Johnson Vision Care
    • 8.3.1.1. Company Overview
    • 8.3.1.2. Financial Performance
    • 8.3.1.3. Service Benchmarking
    • 8.3.1.4. Strategic Initiatives
  • 8.3.2. Alcon Vision LLC
    • 8.3.2.1. Company Overview
    • 8.3.2.2. Financial Performance
    • 8.3.2.3. Service Benchmarking
    • 8.3.2.4. Strategic Initiatives
  • 8.3.3. Carl Zeiss Meditec AG
    • 8.3.3.1. Company Overview
    • 8.3.3.2. Financial Performance
    • 8.3.3.3. Service Benchmarking
    • 8.3.3.4. Strategic Initiatives
  • 8.3.4. Bausch & Lomb Incorporated
    • 8.3.4.1. Company Overview
    • 8.3.4.2. Financial Performance
    • 8.3.4.3. Service Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. Essilor International S.A
    • 8.3.5.1. Company Overview
    • 8.3.5.2. Financial Performance
    • 8.3.5.3. Service Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. Ziemer Ophthalmic Systems Ltd
    • 8.3.6.1. Company Overview
    • 8.3.6.2. Financial Performance
    • 8.3.6.3. Service Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. Nidek Co. Ltd.
    • 8.3.7.1. Company Overview
    • 8.3.7.2. Financial Performance
    • 8.3.7.3. Service Benchmarking
    • 8.3.7.4. Strategic Initiatives
  • 8.3.8. TOPCON CORPORATION
    • 8.3.8.1. Company Overview
    • 8.3.8.2. Financial Performance
    • 8.3.8.3. Service Benchmarking
    • 8.3.8.4. Strategic Initiatives
  • 8.3.9. Haag-Streit Group
    • 8.3.9.1. Company Overview
    • 8.3.9.2. Financial Performance
    • 8.3.9.3. Service Benchmarking
    • 8.3.9.4. Strategic Initiatives
  • 8.3.10. Glaukos Corporation
    • 8.3.10.1. Company Overview
    • 8.3.10.2. Financial Performance
    • 8.3.10.3. Service Benchmarking
    • 8.3.10.4. Strategic Initiatives